Moreover, some research demonstrated that KMT2D is essential for tumor cell proliferation in many solid tumors, including pancreatic cancer, breast and colorectal cancer, and that KMT2D depletion increases the effectiveness of chemotherapy [9–12]. This evidence concerns the gene KMT2D and colorectal cancer.